|
Medication Information:
Trifluoperazine (generic) - Stelazine
(brand)
Classification: High-potency phenothiazine
antipsychotic
Common Usage: To reduce the symptoms of psychotic
disorders. It also has been used for the short-term treatment of
severe vomiting and for severe generalized anxiety
disorder.
Important Side Effects: Most people given trifluoperazine
will be drowsy after the first few doses, but this subsides with
continued use. Taking the entire dose of trifluoperazine at bedtime
is usually as effective as taking several daily doses, and can
improve sleep and reduce sedation during the day. Some people may
feel dizzy upon standing due to a drop in blood pressure. If you
become dizzy, sit or lay down immediately and the dizziness should
go away. Standing up slowly will reduce this problem in most
people.
Trifluoperazine can cause dry mouth, blurry near vision,
constipation, and occasionally a rapid heart rate. These side
effects also can occur from other medications your doctor might
prescribe to reduce movement disorders that trifluoperazine may
cause. Sucking on sugarless candy or using artificial saliva,
available at a pharmacy, can reduce dry mouth. Constipation can be
relieved by drinking more water, exercising regularly and eating a
high-fiber diet (whole grains and fruit, for example). If this
isnt effective ask your pharmacist for a stool softener or
bulk-forming laxative.
Several types
of movement disorders, sometimes called extrapyramidal
symptoms or "BPS," are associated with the use of
trifluoperazine. While common, they are rarely severe. Always bring
this to the attention of the prescriber. Akathisia, is a
feeling of restlessness, jumpiness, or the need to keep moving. It
increases with the dose of trifluoperazine. Dystonias are
severe muscle spasms of the neck, eyes, or other muscles. They
occur within the first week of use or dose change and are rapidly
treated with medications that can be given by injection, if needed.
If you begin to have difficulty breathing, get medical assistance
immediately. Younger people are more likely to have dystonias than
older people, especially if large doses are started once daily
instead of split up into several smaller doses.
Parkinsonism
or pseudoparkinsonian symptoms may occur on trifluoperazine as
well. Symptoms include trembling or shaking of the hands and
fingers, difficulty speaking or swallowing, loss of balance,
shuffling walk or stiffness in the arms or legs. These symptoms are
more likely to occur in older people. Tardive dyskinesia is
a movement disorder that causes jerky or writhing movements in the
arms or legs or mouth movements, and is more common in the elderly
or in patients without schizophrenia.
A very rare
condition called neuroleptic malignant syndrome (NMS) can cause
severe muscle rigidity, high fever, altered mental status,
irregular or rapid pulse, and other problems. If untreated, it is
sometimes fatal. Seek medical attention if any of these symptoms
last more than a couple of hours. Always use a sunblock (SPF 15 or
greater) as trifluoperazine can cause rapid sunburn and altered
body temperature regulation. Avoid excessively hot or cold places,
and drink plenty of water.
Sore or
enlarged breasts may occur in men or women on trifluoperazine, as
can lack of menstruation in women, lack of interest in sex, or
failure to achieve orgasm. If you are
pregnant or
plan to become pregnant, you should discuss this with all of your
health care providers in advance. Avoid skin contact with the oral
solution or broken tablets, as it may cause a rash. This is not a
complete list of all known or potential adverse effects.
Notify your prescriber or pharmacist of any symptoms that
concern you that have started since taking this medication,
changing its dose, or adding or changing another medication. Take
care when performing any task (such as driving a car) that requires
your attention, until you have experience with trifluoperazine and
are confident you can perform the task safely.
Interactions with Other Medications: Many medications may
interact with trifluoperazine. For example, medications for high
blood pressure may worsen the dizziness when standing up.
Phenobarbital (Luminal) or carbamazepine (Tegretol) can decrease
the blood level of trifluoperazine. Conversely, antibiotics such as
erythromycin (E-Mycin) can increase trifluoperazine levels. Alcohol
may worsen the sedation and unsteadiness from trifluoperazine and
make the original problem harder to treat. This is not a complete
list of all known or potential drug interactions. To help prevent
problems, always make sure your pharmacist and prescribers know
about all medications you are taking, including over-the-counter
drugs, and any dietary herbal supplements.
Common
Dosages: The starting dose for adolescents and adults with
psychotic disorders is 2 to 5 mg twice daily, with an
optimum dose of 10 to 20 mg daily. Some people may need as much as
40 mg daily for severe psychosis. The starting dose for children
with psychosis is 1 mg once or twice daily. If this drug is started
after conventional anti-anxiety agents fail, the starting dose in
adults for nonpsychotic anxiety is 1 to 2 mg twice daily, with an
optimum dosage of 6 mg daily for no more than 12 weeks. If you
forget to take a dose, take it when you remember.
Identification: Trifluoperazine is available in 1 mg, 2 mg,
5 mg, and 10 mg tablets, and in an oral solution at a
concentration of 10 mg/mL. The oral solution should always be
diluted in at least 4 ounces (120 mL) of juice to mask the bitter
taste. The drug also is available in a short-acting injectable
form.
Storage: Store at normal room temperature (590 F to 860 F)
in a tightly closed, lightand moisture-resistant container. Keep
out of direct sunlight and avoid storing in a warm and humid area,
such as the bathroom or kitchen, to prevent deterioration. Keep all
medications out of the reach of children to prevent accidental
poisoning. Do not take an expired medication. Do not transfer
medication from one container to another. Carefully discard
discontinued medication where children cannot find it.
Edited by
Stephen R. Sakiad, Pharm.D.
A
SERVICE OF Psychopharmacology Update
Note: These guidelines are for general information only. For
more specific information, consult your physician or
pharmacist.
|